175 related articles for article (PubMed ID: 794497)
1. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
[TBL] [Abstract][Full Text] [Related]
2. In vivo suppression of EL 4 lymphomas by rabbit antitumor sera.
Ghose T; Guclu A; Faulkner J; Tal J
J Natl Cancer Inst; 1977 Mar; 58(3):693-700. PubMed ID: 839564
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis and immunotherapy of EL4 lymphoma.
Ghose T; Guclu A; Tai J; Mammen M; Norvell ST
Eur J Cancer (1965); 1977 Sep; 13(9):925-35. PubMed ID: 913475
[No Abstract] [Full Text] [Related]
4. Immunoprophylaxis and cytotoxic effector cells against EL 4 leukemia induced in syngeneic C57BL/6J mice by use of irradiated EL 4 cells.
Johnson TS; Hudson JL; Feldman ME; Irvin GL
J Natl Cancer Inst; 1975 Sep; 55(3):561-7. PubMed ID: 51089
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.
Tai J; Guclu A; Ghose T; Norvell S
Cancer Immunol Immunother; 1983; 15(1):47-53. PubMed ID: 6553507
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
Taniyama T; Azuma I; Yamamura Y
Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
Olsson L; Florentin I; Kiger N; Mathé G
J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
[TBL] [Abstract][Full Text] [Related]
8. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
Check JH; Brady LW; Leipold PL; O'Neill EA
Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
[No Abstract] [Full Text] [Related]
9. Immunopotentiation with BCG: dimensions of a specific antitumor response.
Hawrylko E
J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
[TBL] [Abstract][Full Text] [Related]
10. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.
Parr I
Br J Cancer; 1972 Jun; 26(3):174-82. PubMed ID: 5047141
[TBL] [Abstract][Full Text] [Related]
11. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
Gillette RW; Berringer DC; Wunderlich DA
J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
[TBL] [Abstract][Full Text] [Related]
12. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
13. Effects on tumor growth in vivo by manipulation of the tumor immune response.
Sjögren HO
Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
[No Abstract] [Full Text] [Related]
14. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
Hawrylko E
J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
Rella W; Chaput B
Oncology; 1978; 35(3):136-42. PubMed ID: 209379
[TBL] [Abstract][Full Text] [Related]
16. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
Fass L; Fefer A
Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
[No Abstract] [Full Text] [Related]
17. Suppression of an AKR lymphoma by antibody and chlorambucil.
Ghose T; Guclu A; Tai J
J Natl Cancer Inst; 1975 Dec; 55(6):1353-7. PubMed ID: 1107575
[TBL] [Abstract][Full Text] [Related]
18. Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor.
Reif AE
J Natl Cancer Inst; 1986 Oct; 77(4):899-908. PubMed ID: 3020300
[TBL] [Abstract][Full Text] [Related]
19. Immunological intervention in neoplasia.
Weiss DW
Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
[No Abstract] [Full Text] [Related]
20. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
